Thyroid adenomas belong to the cytogenetically best investigated human epithelial tumors. Cytogenetic studies of about 450 benign lesions allow one to distinguish between different cytogenetic subgroups. Two chromosomal regions, that is, 19q13 and 2p21, are frequently rearranged in these tumors. Although 2p21 aberrations only account for about 10% of the benign thyroid tumors with clonal cytogenetic deviations, 2p21 rearrangements belong to the most common cytogenetic rearrangements in epithelial tumors due to the high frequency of these benign lesions. The 2p21 breakpoint region recently has been delineated to a region of 450 kbp, but the gene affected by the cytogenetic rearrangements still has escaped detection. Positional cloning and 3 0 RACE-PCR allowed us to clone that gene which we will refer to as thyroid adenoma associated (THADA) gene. In cells from two thyroid adenomas characterized by translocations t(2;20;3) (p21;q11.2;p25) and t(2;7)(p21;p15), respectively, we performed 3 0 -RACE-PCRs and found two fusions of THADA with a sequence derived from chromosome band 3p25 or with a sequence derived from chromosome band 7p15. The THADA gene spans roughly 365 kbp and, based on preliminary results, encodes a death receptorinteracting protein.
Introduction
Adenomas of the thyroid are rare examples of epithelial tumors frequently displaying specific chromosomal translocations. There are two chromosomal bands most frequently rearranged by these translocations, that is, 19q13 (Bartnitzke et al., 1989; Bondeson et al., 1989; Dal Cin et al., 1992; Belge et al., 1998) and 2p21 (Teyssier et al., 1990; Belge et al., 1998; Bol et al., 1999) . Both types of translocations apparently do not co-occur in thyroid tumors, thus indicating two independent cytogenetic subgroups. As for the translocation partners there is also no apparent overlap and in both groups other chromosomal regions involved in the translocations remarkably vary. Nevertheless, there are preferred translocation partners that are more often involved than others, as for example chromosomal band 5q13 in cases with 19q13 translocations and band 7p15 in cases with 2p21 translocations. Whereas the breakpoint region of chromosome 19 has been characterized molecularly in detail and candidate genes have been found (Rippe et al., 1999; Belge et al., 2001) , for the 2p21 region only a rough mapping of the breakpoint has been obtained with no candidate genes identified so far (Bol et al., 2001) . Herein, we describe the identification of the target gene of the 2p21 aberrations which we have tentatively referred to as thyroid adenoma-associated gene (THADA). The identification of genes affected by these aberrations and the elucidation of their mechanisms of action certainly will lead to better insights into the pathogenesis of these frequent diseases.
Results
In the thyroid adenoma cell line S325/TSV40 characterized by a translocation t(2;20;3)(p21;q11.2;p25), we found a single chromosome 2 BAC clone, 1069E24, that hybridized to both the der(2) and the der(20) chromosome and thus contained the altered 2p21 gene locus (Bol et al., 2001) (Figure 1 ). Database search based on clone 1069E24 and the flanking BACs 339H12, 183F15, and 204D19 identified numerous anonymous human ESTs (BLAST analysis, version 2.2.6; Altschul et al., 1997) . Alignment and RT-PCR analyses point to a novel gene that we referred to as THADA (Figure 2 ). THADA cDNA contains 38 exons with at least one alternative splice variant ( Figure 3) . As for its possible function, THADA corresponds to the death receptorinteracting protein mRNA encoding a protein that in two-hybrid experiments was found to be a ligand of death receptor DR5 (Puduvalli VK and Ridgway L, GenBank accession reference note). The hypothetical 1954 amino acids (predicted molecular weight: 220 kDa) have no apparent homology to other human proteins as retrieved from public databases. Nevertheless, there are homologies to undefined ESTs in other organisms, as for example the mouse.
The gene is widely expressed as revealed by in silico analyses using serial analysis of gene expression (SAGE) and EST-library database.
EST data show a high expression in adult normal placenta and SAGE data point to a strong expression in breast cancer cell line MCF7 and normal breast epithelium. A multiple Northern blot was probed with an 820 bp fragment from the ORF allowing us to detect a 6.2 kbp signal in all tissues investigated (Figure 4) .
To identify possible THADA fusion partners, we used exon 18 and 28 oligonucleotide primers to perform 3 0 -RACE-PCR in cell lines S325/TSV40 and S533/TSV40. Amplification products were cloned and sequenced leading to the identification of clones in which the sequence diverged from THADA after exon 28. A database search revealed that the sequence fused to THADA in S325/TSV40 (FUS3p) maps to . By database search we have not been able to correlate these sequences to any described gene structures. In order to confirm the fusions in both cell lines, RT-PCR analyses were performed. Amplification products corresponding to those found by RACE-PCR were obtained for both cell lines, thus confirming the THADA-FUS3p and THADA-FUS7p fusions ( Figure 5 ). In both cell lines, THADA stops after exon 28 followed by the fused sequences from either of the translocation partners.
Discussion
Chromosome 2p21 aberrations characterize the second most frequent structural chromosomal rearrangements in benign adenomas of the thyroid (Belge et al., 1998; Bol et al., 1999) . From the results presented herein, there is little doubt that THADA is indeed the target gene of those translocations. In the translocations observed in both cell lines, the identical part of THADA becomes fused to ectopic sequences both mapping to the breakpoints of the translocation partners. Since no similarity of the ectopic sequences with known genes became apparent, it seems tempting to speculate that the truncation of the gene and the protein rather than its fusion to particular coding sequences is the critical event. As for the function of the THADA protein, there is so far only one unpublished report based on twohybrid experiments indicating the involvement of THADA in death receptor pathway (Puduvalli VK and Ridgway L, GenBank accession reference note). We hypothesize that the truncation of the gene, and the loss of the 3 0 part of THADA leads to an alterated apoptosis induction. This may cause an increased proliferation in benign thyroid tumors with chromosome 2p21 alterations. Previous studies revealed that truncation of genes could be an important event in human tumor development. For example, truncation of the 3 0 part of the highmobility group gene HMGA2 could be relevant for the etiology of human sarcomas (Berner et al., 1997) or causes malignant transformation of NIH3T3 cells (Fedele et al., 1998) . Apparently, further elucidation of the function of the THADA protein will be helpful to get insights into the molecular pathogenesis of benign adenomas of the thyroid and possibly also into benign proliferation in general.
Materials and methods

FISH analysis
For chromosome analyses and FISH studies, materials of the cell lines S325/TSV40 and S533/TSV40, derived from a thyroid adenoma, were used. The cell lines were obtained by transfection with a construct containing the SV40 large T antigen, as reported previously (Belge et al., 1992) . Cell culture of the cell lines and chromosome analyses were performed as previously described for pleomorphic adenomas of the parotid gland (Bullerdiek et al., 1987) . The BAC clones were obtained from the RP-11-Library (RZPD, Heidelberg, Germany). DNA of BAC clones was isolated using the QIAGEN Plasmid Midi Kit (QIAGEN, Hilden, Germany). FISH analyses were performed after GTG banding of the same metaphase spreads. Treatment of metaphases and subsequent FISH experiments were performed using the protocol of Kievits et al. (1990) . For FISH studies, BAC DNA was labeled either with dig-11-dUTP or biotin-16-dUTP by nick translation (Roche Diagnostics, Mannheim, Germany). For two-color FISH experiments, the labeled BAC DNA was pooled (concentration: 4 ng/ml). For one-color FISH, 4 ng/ml of each BAC clone was used. Detection was performed with anti-dig-fluorescein fab-fragments (Roche Diagnostics, Mannheim, Germany) and Cy3-conjugated streptavidin (Jackson Immuno Research, West In lane 1, three amplification products of the cell line S325T/SV40 representing the three splice variants (165, 283 and 448 bp) of THADA-FUS3p were seen. In S533T/SV40, the fusion transcripts THADA-FUS7p were detected as 704 and 830 bp PCR products, as shown in lane 4. Both RT-PCRs confirmed the existence of THADA-FUS3p and THADA-FUS7p. In lanes 2 and 5, RT-PCR analyses with the same primers used on the cell lines were performed on normal thyroid with no detectable products. DNA molecular weight marker 1 kb-plus ladder (Invitrogen, Karlsruhe, Germany) is seen in lane 3
V Rippe et al
Grove, PA, USA). Chromosomes were counterstained with DAPI (0.025 mg/ml). For each cell line, at least 10 metaphases were examined. Slides were analysed on a Zeiss Axiophot fluorescence microscope using an FITC, Cy3, and DAPI filter set. Metaphases were recorded with the Power Gene Karyotyping System (Applied Imaging, Newcastle, UK).
PCR analyses
Total RNA was isolated from cells of S325/TSV40 and S533/ TSV40 using TRIzol reagent (Invitrogen, Karlsruhe, Germany). Total RNA (5 mg) was reverse transcribed into firststrand cDNA by M-MLV Reverse Transcriptase (Invitrogen, Karlsruhe, Germany). For 3 0 -RACE-PCR, a gradient thermocycler (Biometra, Go¨ttingen, Germany) was used. Amplifications were carried out in a final volume of 50 ml containing 1.5 ml template cDNA, 1 Â AdvanTaqPlus buffer, 0.2 mm of each primer, 200 mm dNTP mix, and 1 ml 50Â AdvanTaq cDNA Polymerase Mix. Primer sequences used for 3 0 -RACE were: 5 0 -GCTTCAGGCAGCAGCAGCATTTCCA-3 0 (exon 18) and 5 0 -AGACTCTACGCTTCCCCGATGGATGGT-3 0 (exon 28). The PCR reaction was performed according to the Advantage cDNA PCR Kit manual (Clontech, Palo Alto, CA, USA). After an initial denaturation at 941C for 5 min, 35 cycles were performed. Each cycle consisted of denaturation (941C) for 30 s and a combined annealing/extension step for 6 min at 681C. 3 0 -RACE was completed with a final extension for 6 min at 681C. RACE products were separated on a 1.2% agarose gel and transferred onto nylon membrane Hybond-N þ (Amersham Pharmacia Biotech, Little Chalfont, England) in 20 Â SSC followed by UV crosslinking. Probe DNA (201 bp) was labeled with dig-11-dUTPs in a PCR reaction on a cDNA clone containing a THADA-sequence using primers 5 0 -GCTTCAGGCAGCAGCAGCATTTCCA-3 0 and 5 0 -ATTG GGATGAGGCCTTCAGGGGATGA-3 0 . Labeling, hybridization, and detection were performed according to the manufacturer's protocol (Roche Diagnostics, Mannheim, Germany). RT-PCR detection of the fusion genes was performed with primers 5 0 -AGACTCTACGCTTCCCC-GATGGATGGT-3 0 5 0 -TCCAGGGAAATTCACTGCTTTG GGAGCCA-3 0 (THADA-FUS3p) and 5 0 -AGACTCTACG CTTCCCCGATGGATGGT-3 0 5 0 -GGTAGCGGGAGCAAT CACAAAACTGTAA-3 0 (THADA-FUS7p). Amplifications were carried out in a final volume of 50 ml containing 0.5 ml template cDNA, 0.05 U/ml Taq DNA Polymerase recombinant (Invitrogen, Karlsruhe, Germany), 0.2 mm of each primer, 200 mm dNTP mix, and 1 Â PCR R Â N Puffer (Invitrogen, Karlsruhe, Germany). After an initial denaturation at 941C for 3 min, 35 cycles were performed. Each cycle consisted of denaturation (941C) for 45 s, annealing for 45 s (581C, THADA-FUS3p; 601C, THADA-FUS7p), and extension for 1 min at 721C.
Northern blot hybridization
Expression patterns of THADA were studied using a commercially available Northern blot membrane (Human Endocrine System MTN Blot, Clontech, Palo Alto, CA, USA). A partial cDNA clone of THADA was labeled with 32 P by random primer extension (Feinberg and Vogelstein, 1983) and used as molecular probe. The probe was amplified by PCR using primers 5 0 -AGAGTAAATCCAAACGTGAACCAGA-GAATGAGT-3 0 and 5 0 -ATTGGGATGAGGCCTTCAGGG-GATGA-3 0 . Hybridization was carried out as described (Rippe et al., 1999) , with 30 min prehybridization and hybridization for 1 h at 681C. The membranes were washed four times for 10 min at room temperature in 2 Â SSC/0.05% SDS, and twice for 20 min at 501C in 0.1 Â SSC/0.1% SDS. Signals were visualized by using a STORM phosphorimager 860 (Amersham Pharmacia Biotech, Little Chalfont, England).
The GenBank Accession numbers are: THADA, AY149629; THADA-FUS3p, AY149630; THADA-FUS3pA, AY149631; THADA-FUS7p, AY149632; THADA-A2, AY149633; death receptor-interacting protein mRNA, AF323176; BAC clones from RPC-11: 1069E24, AQ694385, AQ703756; 339H12, AC010883; 183F15, AC092838; 204D19, AC092615; 167M22, AC093174; 379L16, AC079780.
